Orchid Chemicals & Pharmaceuticals Articles
News briefs from Genzyme, Sagent, Orchid and Kyowa Hakko
14 November 2012
Hospira to acquire Orchid API production and R&D facility
30 August 2012
As US District Court dismisses patent use code counterclaim, all eyes move to the Supreme Court Prandin case, says law firm
22 November 2011
Hospira to buy Orchid's generic injectable business for $400 million
16 December 2009
India's Orchid buys out rest of Bexel
14 August 2006
Alpharma in deal with India's Orchid
7 March 2005
India's Orchid to buy Mano Pharma
6 January 2003
India's Orchid sets up JV in China
28 January 2002
Orchid of India shelves plans for factory
20 January 2000
Orchid looks for more foreign investment
2 September 1999
Orchid looking to attract more foreign investment
20 August 1999
Showing 1-13 of 13 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
